LEADER 02045nas  2200649-a 450 
001 996216246903316
005 20240430163237.0
011   $a1098-2264
035   $a(DE-599)ZDB1492641-6
035   $a(OCoLC)38748182
035   $a(CKB)954925590417
035   $a(CONSER)sn-98009127-
035   $a(EXLCZ)99954925590417
100   $a19980319a19899999  s--         a
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aGenes, chromosomes & cancer
210   $a[New York, N.Y.] $cWiley-Liss, Inc
300   $aRefereed/Peer-reviewed
300   $aPublished: Hoboken, N.J., <2005->
311   $a1045-2257 
517 3 $aGenes, chromosomes, and cancer
531   $aGENE CHROMOSOMES CANCER
531   $aGENE CHROMOSOME CANCER
531   $aGENE CHROMOSOME CANC
531   $aGENE CHROM
531   $aGENES CHROMOSOMES AND CANCER
531   $aGENES CHROMOSOMES CANCER
531 0 $aGenes, chromosomes cancer
606   $aCancer$xGenetic aspects$vPeriodicals
606   $aChromosome abnormalities
606   $aCell Transformation, Neoplastic
606   $aChromosome Aberrations
606   $aCancer$xAspect génétique$vPériodiques
606   $aAberrations chromosomiques
606   $aChromosome abnormalities$2fast$3(OCoLC)fst00860059
606   $aCancer$xGenetic aspects$2fast$3(OCoLC)fst00845368
608   $aPeriodical
608   $aPeriodicals.$2fast
608   $aPeriodicals.$2lcgft
608   $aPériodiques.$2rvmgf
615  0$aCancer$xGenetic aspects
615  0$aChromosome abnormalities.
615  2$aCell Transformation, Neoplastic
615  2$aChromosome Aberrations
615  6$aCancer$xAspect génétique
615  6$aAberrations chromosomiques.
615  7$aChromosome abnormalities.
615  7$aCancer$xGenetic aspects.
676   $a616
906   $aJOURNAL
912   $a996216246903316
996   $aGenes, chromosomes & cancer$91938226
997   $aUNISA